248507.fig.002
Figure 2: EGAS viability progression analysis and subsequent assessment in an organotypic culture following the excision from the patient and maintenance as EGAS in aCSF for 7 hours (represented as 0 hour in organotypic culture), the NDV-V4UPM treated EGAS showed a significant** reduction in the number of viable cells until 48 hours but regrowth at 72 hours, whilst mock-infected EGAS showed persistent growth with an increased number of viable cells. Error bars represent the ±SE.